TECH · 10-Q/A · 2026Q3 · Full report
Revenue Performance and Mix
BIO-TECHNE Corp · 2026-11-12 · Importance 49 · Surprise 32 · Matches filing data
Quarterly net sales increased 4.6% year over year to $299.7 million from $286.6 million. Consumables revenue rose 2.4% to $237.3 million, instrument revenue rose 16.8% to $25.5 million, and service revenue declined 18.3% to $22.5 million. Royalty revenue increased 156.7% to $14.5 million from $5.6 million, raising its share of total revenue to 4.8% from 2.0%. Protein Sciences revenue increased 8.7% to $219.7 million, while Diagnostics and Spatial Biology revenue increased 0.9% to $80.2 million.
Key facts
- Consolidated net sales for the quarter ended September 30, 2026 were $299.7 million, up 5% year over year; organic revenue increased 7%, foreign currency impact was immaterial, and businesses held-for-sale had an unfavorable 2% impact. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | realized | +4.8% | Consolidated net sales for the quarter ended September 30, 2026 were $299.7 million, up 5% year over year; organic revenue increased 7%,… |